APOE and tauopathy: Notably, partial reduction in APOE4 expression, either globally or in specific cell types like astrocytes or neurons, significantly attenuates tauopathy, neuroinflammation, synaptic loss, and brain atrophy, highlighting the therapeutic potential of APOE4 silencing in tau-driven neurodegeneration [43,55,147].